Abstract:Abstract Animal models of erythropoiesis related genes have been limited by the fact that some of these genes have non-erythroid expression and other functions in addition to erythropoiesis and thus their knock-out may be embryonic lethal. Tissue specific knock-out or knock-in mice models employing GATA-1-Cre and other constructs showed that these promoters are also active in non-hematopoietic tissues, i.e. GATA-1 has activity in early embryonic development and in neuronal tissue. Suzuki et al (Blood, 2002, 100; 2279) isolated the GATA-1 locus hematopoietic regulatory domain (GATA-1-HRD) and demonstrated that the expression of a transgene under its control is limited to the hematopoietic tissue. We generated a transgenic mouse expressing an improved Cre (iCre) under GATA-1-HRD promoter control. This mouse was crossbred with ROSA 26 mouse and the progeny was examined for tissue specificity of iCre expression using beta-galactosidase staining. Brain, spleen, kidney, heart, thymus, liver, lung and ovary were examined for whole organ LacZ staining. All tested organs were negative except kidney and spleen where some positivity was observed. Subsequently, we prepared tissue sections from kidney, spleen and bone marrow and stained with LacZ and anti-beta-galactosidase antibody. Only the bone marrow EpoR expressing cells were positive; the kidney and the spleen cells were negative. Although Suzuki et al previously showed expression of the GATA-1-HRD driven erythropoietin receptor in spleen using RT-PCR, we were not able to find iCre expression in the splenic cells using these approaches. We demonstrate that our transgenic mouse (GATA-1-HRD-iCre) showed a restricted iCre expression in hematopoietic tissue that differs from previous studies of other hematopoiesis specific cre mouse. We conclude that this mouse model should be useful in studies of function of erythroid specific genes.

Second-generation Notch1 Activity-Trap Mouse Line (n1ip::crehi) Provides a More Comprehensive Map of Cells Experiencing Notch1 Activity.

Mapping the Consequence of Notch1 Proteolysis in Vivo with NIP-CRE

The Wnt1-Cre2 transgene causes aberrant recombination in non-neural crest cell types

In Vivo Visualization of Notch1 Proteolysis Reveals the Heterogeneity of Notch1 Signaling Activity in the Mouse Cochlea

Neuropilin-2 genomic elements drive cre recombinase expression in primitive blood, vascular and neuronal lineages

Notch1 Phase Separation Coupled Percolation facilitates target gene expression and enhancer looping

Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines

Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells

Construction and Identification of the Eukaryotic Expression Vector of Human Notch 1 Intracellular Domain

Identification of the Transgene Integration Site and Host Genome Changes in MRP8-Cre/ires-EGFP Transgenic Mice by Targeted Locus Amplification

A Transgenic Cre Mouse Line for the Study of Cortical and Hippocampal Development

Comparative analysis of two independent Myh6-Cre transgenic mouse lines

Construction and identification of Notch1 gene induced T-cell leukemia with double florescence tracer in transgenic zebrafish

The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis

A new recombinase mouse line to target intrinsically photosensitive retinal ganglion cells (ipRGCs)

Abstract 14700: Notch1 Overexpression Reprograms Adult Myocytes to an Immature Functional Phenotype

Engineering of an Enhanced Synthetic Notch Receptor by Reducing Ligand-Independent Activation

Transgenic mice with hematopoietic and lymphoid specific expression of Cre

A New Prdm1-Cre Line is Suitable for Studying the Second Heart Field Development

Hematopoietic Specific GATA-1-Improved Cre Mouse for Erythroid-Specific Gene Modification.